Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

CME

  • It’s Time to Abandon Fecal Occult Blood Testing in the Emergency Department

    If a test result does not impact management of a patient—or, worse, is misleading—should the test even...
  • What Emergency Physicians Need to Know About Anti-Inflammatory Monoclonal Antibodies

    If you watch network prime-time news programs at all, you can’t help but be impressed by the...
  • Fluoroquinolones Are in the FDA Spotlight Again

    During FOAMcast, we like to cover guidelines that affect emergency physicians. But we don’t just cover the...

It’s Time to Abandon Fecal Occult Blood Testing in the Emergency Department

August 22, 2019 - Ryan Patrick Radecki, MD, MS - 7 Comments

If a test result does not impact management of a patient—or, worse, is misleading—should the test even…

Read More

What Emergency Physicians Need to Know About Anti-Inflammatory Monoclonal Antibodies

August 6, 2019 - W. Richard Bukata, MD - 0 Comment

If you watch network prime-time news programs at all, you can’t help but be impressed by the…

Read More

Fluoroquinolones Are in the FDA Spotlight Again

June 14, 2019 - Jeremy Samuel Faust, MD, MS; and Lauren Westafer, DO - 0 Comment

During FOAMcast, we like to cover guidelines that affect emergency physicians. But we don’t just cover the…

Read More

Factor Xa Inhibitor Reversal Agent Is Not Ready for Prime Time

May 2, 2019 - Ryan Patrick Radecki, MD, MS - 0 Comment

Ever since the release of direct-acting oral anticoagulants, emergency physicians have been tasked with managing their associated…

Read More

A Rational Approach to Pulmonary Embolism Evaluation

March 15, 2019 - Anton Helman, MD, CCFP(EM), FCFP - 1 Comment

Emergency department over-investigation is, perhaps, nowhere more pervasive than in the workup of suspected pulmonary embolism (PE)….

Read More

A Case Example: Reversing Anticoagulant Dabigatran with Idarucizumab

February 5, 2019 - W. Richard Bukata, MD - 0 Comment

The Case A 75-year-old man presents to your emergency department via paramedics. His transport time was about…

Read More

New-Drug Details: Reversing Anticoagulant Dabigatran with Idarucizumab

February 5, 2019 - Mary Choy, PharmD, BCGP, FASHP - 1 Comment

Idarucizumab (Praxbind) is the first and only specific reversal agent for a novel oral anticoagulant (NOAC) approved…

Read More

Important Information about the Seasonal Acute Flaccid Myelitis Outbreak

December 17, 2018 - David E. Hogan, DO, MPH, FACEP - 0 Comment

Nothing is more concerning to parents and emergency health care providers than a serious illness that primarily…

Read More

Defining Sepsis Then & Now, Part 1

December 4, 2018 - Tiffany M. Osborn, MD, MPH - 0 Comment

Epidemiology 1979–2000 Before 2000, solid epidemiology data on sepsis were lacking. No formalized, generally accepted definition existed,…

Read More

A 3-Step Approach for Infants with Congenital Heart Disease

May 18, 2018 - Anton Helman, MD, CCFP(EM), FCFP - 4 Comments

The traditional approach to congenital heart disease (CHD) involves a detailed understanding of the pathophysiology, clinical findings,…

Read More
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›
  • »

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603